No Time to Lose: Cases of Anticoagulant Reversal Before Thrombolysis in Acute Ischemic Stroke Patients

被引:7
作者
Amin, Sheyar [1 ]
Kasischke, Karl A. [1 ]
Elsayed, Kareem [1 ]
Burgin, W. Scott [1 ]
Rose, David Z. [1 ]
机构
[1] Univ S Florida, Morsani Coll Med, Neurol, Tampa, FL 33620 USA
关键词
anticoagulation reversal; thrombolytic; ischemic stroke; anticoagulation therapy; atrial fibrillation; WARFARIN; IDARUCIZUMAB; DABIGATRAN;
D O I
10.7759/cureus.21406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Direct oral anticoagulant (DOAC) reversal before intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) patients is well-documented in Europe, specifically for dabigatran: the selective humanized monoclonal antibody fragment idarucizumab, given to neutralize dabigatran prior to IVT, was associated with improved outcomes post-IVT. However, in the United States, this approach is rarely reported and not endorsed by guidelines. Therefore, further reporting on this is needed and neuroradiographic correlation may help validate this concept. At our hospital in Tampa, Florida, two octogenarians with atrial fibrillation, adherent with the DOAC dabigatran, presented with AIS shortly after symptom onset. Both received idarucizumab, then IVT. Clinical outcomes, treatment times, and perfusion-based neuroradiographic parameters were assessed. Patient A had a 41 ml penumbra on computed tomography perfusion (CTP) scan that decreased to 15 ml in final infarct volume on follow-up imaging, resulting in a 26 ml penumbral salvage (63.4%), and National Institutes of Health Stroke Scale (NIHSS) improved from 11 to 9. Patient 11 had a 23 ml penumbra on CTP that decreased to 0.5 ml on follow-up imaging, resulting in a 22.5 ml penumbral salvage (97.8%), and NIHSS improved from 9 to 4. Neither developed bleeding complications. Both had delayed door-to-needle times but nevertheless demonstrated clinical neurological improvements. In our limited experience, IVT after immediate DOAC reversal in AIS patients on dabigatran was associated with clinical improvement in NIHSS by 2 to 5 points (with no neuroworsening), and penumbral salvage of ischemic brain tissue on neuroimaging ranging from 63.4% to 97.8%. Further reporting on this may lead to greater IVT use and better outcomes in "DOAC failures", especially for patients without other acute treatment options such as mechanical thromhectomy. Research into other anticoagulant reversal agents pre-IVT in AIS is also warranted.
引用
收藏
页数:5
相关论文
共 15 条
[1]   European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke [J].
Berge, Eivind ;
Whiteley, William ;
Audebert, Heinrich ;
Marchis, Gian Marco De ;
Fonseca, Ana Catarina ;
Padiglioni, Chiara ;
Ossa, Natalia Perez de la ;
Strbian, Daniel ;
Tsivgoulis, Georgios ;
Turc, Guillaume .
EUROPEAN STROKE JOURNAL, 2021, 6 (01) :I-LXII
[2]   Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator [J].
Bissig, David ;
Manjunath, Rashmi ;
Traylor, Brittany R. ;
Richman, David P. ;
Ng, Kwan L. .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (06) :E102-E104
[3]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[4]   Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion [J].
Diener, H. C. ;
Bernstein, R. ;
Butcher, K. ;
Campbell, B. ;
Cloud, G. ;
Davalos, A. ;
Davis, S. ;
Ferro, J. M. ;
Grond, M. ;
Krieger, D. ;
Ntaios, G. ;
Slowik, A. ;
Touze, E. .
INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (01) :9-12
[5]   Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature [J].
Frol, Senta ;
Sagris, Dimitrios ;
Pretnar Oblak, Janja ;
Sabovic, Miso ;
Ntaios, George .
FRONTIERS IN NEUROLOGY, 2021, 12
[6]   Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].
Giugliano, Robert P. ;
Ruff, Christian T. ;
Braunwald, Eugene ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Halperin, Jonathan L. ;
Waldo, Albert L. ;
Ezekowitz, Michael D. ;
Weitz, Jeffrey I. ;
Spinar, Jindrich ;
Ruzyllo, Witold ;
Ruda, Mikhail ;
Koretsune, Yukihiro ;
Betcher, Joshua ;
Shi, Minggao ;
Grip, Laura T. ;
Patel, Shirali P. ;
Patel, Indravadan ;
Hanyok, James J. ;
Mercuri, Michele ;
Vogelmann, O. ;
Gonzalez, C. ;
Ahuad Guerrero, R. ;
Rodriguez, M. ;
Albisu, J. ;
Rosales, E. ;
Allall, O. ;
Reguero, M. ;
Alvarez, C. ;
Garcia, M. ;
Ameriso, S. ;
Ameriso, P. ;
Amuchastegui, M. ;
Caceres, M. ;
Beloscar, J. ;
Petrucci, J. ;
Berli, M. ;
Budassi, N. ;
Valle, M. ;
Bustamante Labarta, G. ;
Saravia, M. ;
Caccavo, A. ;
Fracaro, V. ;
Cartasegna, L. ;
Novas, V. ;
Caruso, O. ;
Saa Zarandon, R. ;
Colombo, H. ;
Morandini, M. ;
Cuello, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104
[7]   Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].
Granger, Christopher B. ;
Alexander, John H. ;
McMurray, John J. V. ;
Lopes, Renato D. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Al-Khalidi, Hussein R. ;
Ansell, Jack ;
Atar, Dan ;
Avezum, Alvaro ;
Cecilia Bahit, M. ;
Diaz, Rafael ;
Easton, J. Donald ;
Ezekowitz, Justin A. ;
Flaker, Greg ;
Garcia, David ;
Geraldes, Margarida ;
Gersh, Bernard J. ;
Golitsyn, Sergey ;
Goto, Shinya ;
Hermosillo, Antonio G. ;
Hohnloser, Stefan H. ;
Horowitz, John ;
Mohan, Puneet ;
Jansky, Petr ;
Lewis, Basil S. ;
Luis Lopez-Sendon, Jose ;
Pais, Prem ;
Parkhomenko, Alexander ;
Verheugt, Freek W. A. ;
Zhu, Jun ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992
[8]   Intravenous tPA (Tissue-Type Plasminogen Activator ) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke [J].
Jin, Chen ;
Huang, Ryan J. ;
Peterson, Eric D. ;
Laskowitz, Daniel T. ;
Hernandez, Adrian F. ;
Federspiel, Jerome J. ;
Schwamm, Lee H. ;
Bhatt, Deepak L. ;
Smith, Eric E. ;
Fonarow, Gregg C. ;
Xian, Ying .
STROKE, 2018, 49 (09) :2237-2240
[9]   Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases [J].
Kermer, Pawel ;
Eschenfelder, Christoph C. ;
Diener, Hans-Christoph ;
Grond, Martin ;
Abdalla, Yasser ;
Abraham, Alexej ;
Althaus, Katharina ;
Becks, Gebhard ;
Berrouschot, Joerg ;
Berthel, Joerg ;
Bode, Felix J. ;
Burghaus, Lothar ;
Canguer, Hakan ;
Daffertshofer, Michael ;
Edelbusch, Sebastian ;
Eggers, Juergen ;
Gerlach, Ruediger ;
Groeschel, Klaus ;
Grosse-Dresselhaus, Florian ;
Guenther, Albrecht ;
Haase, Claus G. ;
Haensch, Carl-Albrecht ;
Harloff, Andreas ;
Heckmann, Joseph G. ;
Held, Valentin ;
Hieber, Maren ;
Kauert, Andreas ;
Kern, Rolf ;
Kerz, Thomas ;
Koehrmann, Martin ;
Kraft, Peter ;
Kuehnlein, Peter ;
Latta, Jan ;
Leinisch, Elke ;
Lenz, Arne ;
Leithner, Christoph ;
Neumann-Haefelin, Tobias ;
Maeurer, Mathias ;
Muellges, Wolfgang ;
Nolte, Christian H. ;
Obermann, Mark ;
Partowi, Someieh ;
Patzschke, Peer ;
Poli, Sven ;
Pulkowski, Ulrich ;
Purrucker, Jan ;
Rehfeldt, Torsten ;
Ringleb, Peter A. ;
Roether, Joachim ;
Rossi, Raluca .
INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (06) :609-618
[10]   Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment [J].
Meyer, Dawn ;
Chu, Frank ;
Derry, Katrina ;
Hailey, Lovella .
JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 59 :355-357